Browsing: Novo Nordisk
Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ’major’ tariffs
Europe’s biggest pharmaceutical companies confronted European Commission President Ursula von der Leyen yesterday as Donald Trump promised the imminent arrival…
“A Healing Tide” was the name of The War and Treaty’s 2018 debut album. But that could also describe what…
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes…
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…
Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy
The CEO of the Novo Nordisk Foundation (NNF), the philanthropic arm of the Danish Ozempic-making pharmaceutical giant, says Denmark is…
Initial prescriptions for the drug are expected to be issued in Shanghai this week, Yicai news service reported Monday. Wegovy…
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
In June, the Supreme Court overturned the decades-old Chevron doctrine that empowered a federal agency’s “reasonable interpretation of ambiguous federal…












